Celularity (CELU) Goodwill & Intangibles (2019 - 2025)
Celularity (CELU) posted quarterly Goodwill & Intangibles of $15.1 million for Q4 2025, up 87.68% year-over-year from $8.0 million in Q4 2024, and up 87.68% quarter-over-quarter from $8.0 million in Q3 2025.
Celularity (CELU) Goodwill & Intangibles (2019 - 2025) Analysis & Trends
Celularity (CELU) has reported Goodwill & Intangibles for 7 consecutive years, with $15.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Goodwill & Intangibles rose 87.68% year-over-year to $15.1 million; the TTM figure through Dec 2025 stood at $15.1 million (up 87.68% YoY), while the FY2025 annual figure was $15.1 million, up 87.68% from the prior year.
- Goodwill & Intangibles improved to $15.1 million in Q4 2025 per CELU's latest filing, from $8.0 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $247.0 million in Q3 2021 and bottomed at $8.0 million in Q4 2024.
- Historically, Goodwill & Intangibles has averaged $82.9 million across 5 years, with a median of $18.6 million in 2023.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles tumbled 91.88% — and 2025, when it soared 87.68%.
- Celularity's Goodwill & Intangibles stood at $246.5 million in 2021, then sank by 46.37% to $132.2 million in 2022, then plunged by 86.12% to $18.3 million in 2023, then tumbled by 56.14% to $8.0 million in 2024, then jumped by 87.68% to $15.1 million in 2025.
- Business Quant data shows CELU's Goodwill & Intangibles at $15.1 million in Q4 2025, $8.0 million in Q3 2025, and $8.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.10 Mn |
| Sep 30, 2025 | 8.05 Mn |
| Jun 30, 2025 | 8.05 Mn |
| Mar 31, 2025 | 16.23 Mn |
| Dec 31, 2024 | 8.05 Mn |
| Sep 30, 2024 | 16.27 Mn |
| Jun 30, 2024 | 16.65 Mn |
| Mar 31, 2024 | 17.10 Mn |
| Dec 31, 2023 | 18.35 Mn |
| Sep 30, 2023 | 18.90 Mn |
| Jun 30, 2023 | 102.17 Mn |
| Mar 31, 2023 | 210.51 Mn |
| Dec 31, 2022 | 132.19 Mn |
| Sep 30, 2022 | 136.35 Mn |
| Jun 30, 2022 | 136.90 Mn |
| Mar 31, 2022 | 137.45 Mn |
| Dec 31, 2021 | 246.49 Mn |
| Sep 30, 2021 | 247.04 Mn |
| Dec 31, 2020 | 248.68 Mn |
| Dec 31, 2019 | 127.07 Mn |